GGrantIndex
Sort

50,496 grants matching lung cancer

Gene Expression in Nonspecific Orbital Inflammatory Disease

$649,406
James T Rosenbaum · Oregon Health & Science University · R01 · FY2019 · EY

Gene Expression in Nonspecific Orbital Inflammatory Disease

$649,406
James T Rosenbaum · Oregon Health & Science University · R01 · FY2017 · EY

The Emphysematous Microenvironment Promotes Lung Tumorigenesis and Progression

$649,363
John J Reilly · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · HL

Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial

$649,306
Claudine Isaacs · Georgetown University · N01 · FY2009 · CA

A nationwide population-based study investigating the cardiovascular effects of exposure to particulate matter α-, β-, and γ-activities and individual radionuclides

$649,282
Antonella Zanobetti · Harvard University D/B/A Harvard School Of Public Health · R01 · FY2025 · ES

Novel Integrative Approach for the Early Detection of Lung Cancer using Repeated Measures

$649,247
Fabien Maldonado · Vanderbilt University Medical Center · R01 · FY2025 · CA

Signal Transduction by Tyrosine Phosphorylation

$649,169
Tony R. Hunter · Salk Institute For Biological Studies · R01 · FY2014 · CA

Caregiver Coping Skills training for Lung Cancer

$649,161
Duke University · R01 · FY2004 · CA

Core-009

$649,099
Caryn Lerman · University Of Southern California · P30 · FY2020 · CA

Core-009

$649,099
Caryn Lerman · University Of Southern California · P30 · FY2019 · CA

Core-009

$649,099
Peggy J Farnham · University Of Southern California · P30 · FY2018 · CA

Mechanics of Monolayer Migration

$649,047
Jeffrey J Fredberg · Harvard School Of Public Health · R01 · FY2011 · HL

Developing CDK12 inhibitors to overcome therapy resistance in HER2+ and KRAS driven breast and lung cancers

$649,046
Derek Ronald Duckett · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA

Protecting the kidney from cisplatin induced injury and progression to chronic kidney disease

$649,021
Leah J Siskind · University Of Louisville · R01 · FY2025 · CA

Lung cancer in never smokers: incidence, risk factors, and molecular characteristics in Asian American, Native Hawaiian and Pacific Islander females

$649,018
Scarlett L Gomez · Cancer Prevention Instit Of California · R01 · FY2016 · CA

Biomolecular Recognition and Binding Mechanisms

$648,880
Ruth Nussinov · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA

Anaplerotic reprogramming of endothelial cells in pulmonary hypertension

$648,802
Ruslan Rafikov · University Of Arizona · R01 · FY2022 · HL

Risk prediction methods

$648,755
Mitchell H Gail · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA

Longitudinal Proteomic and Metabolomic Predictors of Pancreatic Cyst Malignant Progression and Early Stage Pancreatic Cancer

$648,753
Christian Maximillian Schmidt · Indiana University Indianapolis · U01 · FY2022 · CA

Vaccine and radiation for the therapy of human cancers

$648,692
James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Vaccine and Drug Combination Therapy for Human Cancers

$648,692
James Hodge · Division Of Basic Sciences - Nci · ZIA · FY2017 · CA

Targeting tumoral Lactobacillus iners to improve outcomes in cervical cancers

$648,677
Lauren Elizabeth Colbert · University Of Tx Md Anderson Can Ctr · R37 · FY2025 · CA

Prevention of pelvic floor muscle dysfunction with extracellular matrix hydrogel

$648,601
Marianna Alperin · University Of California, San Diego · R01 · FY2020 · HD

Advanced PET/CT Imaging for Improving Clinical Trials

$648,569
Paul E Kinahan · University Of Washington · U01 · FY2017 · CA

Peripheral immune surveillance and long-lived barrier immunity through T cell DC cross-talk

$648,534
Niroshana Anandasabapathy · Weill Medical Coll Of Cornell Univ · R56 · FY2021 · AR